Ovariectomy fails to augment bone resorption and marrow B lymphopoiesis in granulocyte colony-stimulating factor transgenic mice

Journal of Orthopaedic Science

Volumn 10, Issue 1, 2005, Pages 70-76

  Oda, Takashi ^a   Wada, Takuro ^a   Kuwabara, Hiroki ^a   Sawada, Norimasa ^a   Yamashita, Toshihiko ^a   Kokai, Yasuo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B lymphopoiesis; Estrogen; G CSF; Osteoporosis; Ovariectomy

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 7; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MASS; BONE RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; LYMPHOPOIESIS; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 13244265711     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-004-0851-y     Document Type: Article

References (38)

1. Bernard-Poenaru O, Roux C, Blanque R, et al. Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporos Int 2001;12:769-76.
2. Cenci S, Weitzmann MN, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α. J Clin Invest 2000;106:1229-37.
3. Erben RG, Raith S, Eberle J, et al. Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol Endocrinol Metab 1998;274:476-83.
4. Erlandsson MC, Jonsson CA, Islander U, et al. Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 2003;108:346-51.
5. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257:88-91.
6. 2 induces expression of receptor activator of nuclear factor-κB ligand/ osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 2000;15:1321-9.
7. Kawamura H, Kawamura T, Kokai Y, et al. Expansion of extrathymic T cells as well as granulocytes in the liver and other organs of granulocyte-colony stimulating factor transgenic mice: why they lost the ability of hybrid resistance. J Immunol 1999;162:5957-64.
8. Kawasaki K, Gao YH, Yokose S, et al. Osteoclasts are present in gp130-deficient mice. Endocrinology 1997;138:4959-65.
9. Kimble RB, Bain S, Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997;12:935-41.
10. Kitamura H, Kawata H, Takahashi F, et al. Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow. Am J Pathol 1995;147:1682-92.
11. Kokai Y, Kaneko H, Izuka K, et al. Inhibition of resistance to hemopoietic allo-grafts in granulocyte colony-stimulating factor transgenic mice. Eur J Immunol 1996;26:115-9.
12. Kokai Y, Wada T, Oda T, et al. Overexpression of granulocyte colony-stimulating factor induces severe osteopenia in developing mice that is partially prevented by a diet containing vitamin K2 (menatetrenone). Bone (NY) 2002;30:880-5.
13. Kuwabara H, Wada T, Oda T, et al. Overexpression of the granulocyte colony-stimulating factor gene impairs bone morphogenetic protein responsiveness in mice. Lab Invest 2001;81:1133-41.
14. Lang RA, Metcalf D, Cuthbertson RA, et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 1987;51:675-86.
15. Lee MY, Fukunaga R, Lee TJ, et al. Bone modulation in sustained hematopoietic stimulation in mice. Blood 1991;77:2135-41.
16. Lee MY, Fevold KL, Dorshkind K, et al. In vivo and in vitro suppression of primary B lymphocytopoiesis by tumor-derived and recombinant granulocyte colony-stimulating factor. Blood 1993;82:2062-68.
17. Lee MY, Fevold KL, Muguruma Y, et al. Conditions that support long-term production of osteoclast progenitors in vitro. Stem Cells 1997;15:340-6.
18. Manabe N, Kawaguchi H, Chikuda H, et al. Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 2001;167:2625-31.
19. Masuzawa T, Miyaura C, Onoe Y, et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 1994;94:1090-97.
20. Metcalf D. The florey lecture, 1991. The colony-stimulating factors: discovery to clinical use. Philos Trans R Soc Lond B Biol Sci 1991;333:147-73.
21. Metcalf D. Regulatory mechanisms controlling hematopoiesis: principles and problems. Stem Cells 1998;16(suppl)1:3-11.
22. Metcalf D. The molecular control of hematopoiesis: progress and problems with gene manipulation. Stem Cells 1998;16:314-21.
23. Miyamoto T, Ohneda O, Arai F, et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 2001;98:2544-54.
24. Miyaura C, Onoe Y, Inada M, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997;94:9360-5.
25. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11:1043-51.
26. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-96.
27. Purton LE, Lee MY, Torok-Storb B. Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Blood 1996;87:1802-8.
28. Roodman GD. Cell biology of the osteoclast. Exp Hematol 1999;27:1229-41.
29. Sato T, Shibata T, Ikeda K, et al. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 2001;16:2215-21.
30. Sekhar RV, Culbert S, Hoots WK, et al. Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach. Pediatrics 2001;108:E54.
31. Srivastava S, Weitzmann MN, Kimble RB, et al. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest 1998;102:1850-9.
32. Suzuki M, Adachi K, Sugimoto T, et al. The development of bone changes induced in rats by recombinant human granulocyte colony-stimulating factor is suppressed by bisphosphonate. Histol Histopathol 1999;14:679-86.
33. Takahashi T, Wada T, Mori M, et al. Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. Lab Invest 1996;74:827-34.
34. Takamatsu Y, Simmons PJ, Moore RJ, et al. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 1998;92:3465-73.
35. Thorndike EA, Turner AS. In search of an animal model for postmenopausal diseases. Front Biosci 1998;3:c17-26.
36. Van Bezooijen RL, Farih-Sips HCM, Papapoulos SE, et al. IL-1α, IL-1β, IL-6, and TNF-α steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. J Bone Miner Res 1998;13:185-94.
37. Yamada T, Kaneko H, lizuka K, et al. Elevation of lymphocyte and hematopoietic stem cell numbers in mice transgenic for human granulocyte CSF. Lab Invest 1996;74:384-94.
38. Weitzmann MN, Roggia C, Toraldo G, et al. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002;110:1643-50.